InnoCare Pharma concludes subject enrolment Phase II psoriasis trial

The trial aims to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ICP-488 in adult patients.

Related Keywords

China ,Chinese ,Arrivent Biopharma ,Innocare Pharma ,Jasmine Cui , ,Care Pharma ,Clinical Trials Arena ,